We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
20 hedge funds and large institutions have $11M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $11M → $11M (-$60.8K)
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.85M | |
| 2 | +$140K | |
| 3 | +$43.8K | |
| 4 |
CG
Colony Group
Boston,
Massachusetts
|
+$41.7K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$28.4K |
Top Sellers
| 1 | -$257K | |
| 2 | -$180K | |
| 3 | -$35.2K | |
| 4 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
-$34.2K |
| 5 |
Koshinski Asset Management
Decatur,
Illinois
|
-$13.5K |